Daavlin Photera 600 Phototherapy Device Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Daavlin Distributing Company is recalling 26 Photera 600 phototherapy devices nationwide due to incorrect UV sensor calibration affecting output calculations.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 10, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-device.
What Happened
Daavlin Distributing Company initiated a recall because the calibrated output on the Photera 600 was not calculating correctly. The UV Sensor GAIN being applied was incorrect, with GAIN appearing as "4/5" instead of "7" (counts were at ~1000 instead of ~5000).
Which Products Are Affected
The recall involves the Photera 600, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders. A total of 26 units distributed nationwide in the United States are affected. Serial numbers: 6-09033NB4CL, 6-09037NB4CL, 6-09031NB4CL, 6-09538NB4CL, 6-09038NB4CL, 6-09039NB4CL, 6-09040NB4CL, 6-09041NB4CL, 6-09035NB4CL, 6-09034NB4CL, 6-09030NB4CL, 6-09026NB4CL, 6-09023NB4CL, 6-09028NB4CL, 6-09025NB4CL, 6-09043NB4CL, 6-09029NB4CL, 6-09044NB4CL, 6-09022NB4CL, 6-09027NB4CL, 6-09036NB4CL, 6-09045NB4CL, 6-09024NB4CL, 6-07827NB4CL, 6-09539NB4CL, 6-09042NB4CL. The recall number is Z-2743-2026 and it is classified as Class II.
What You Should Do
The recalling firm initiated notification by telephone. No additional consumer instructions are provided in the recall data.
Why This Matters
The device is intended for dermatologic disorders and the calibration error affects output accuracy across 26 units distributed nationwide.
Source
FDA recall number Z-2743-2026, report date 20260722.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,310 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.